Global Infectious Diseases Market Growth (Status and Outlook) 2023-2029

Global Infectious Diseases Market Growth (Status and Outlook) 2023-2029

When infection attacks the body, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic; including antitubercular), antiviral, antifungal and antiparasitic (including antiprotozoal and antihelminthic) agents.

LPI (LP Information)' newest research report, the “Infectious Diseases Industry Forecast” looks at past sales and reviews total world Infectious Diseases sales in 2022, providing a comprehensive analysis by region and market sector of projected Infectious Diseases sales for 2023 through 2029. With Infectious Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Diseases industry.

This Insight Report provides a comprehensive analysis of the global Infectious Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infectious Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infectious Diseases market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Diseases and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Diseases.

The global Infectious Diseases market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

Depending on the severity and the type of infection, the antibiotic may be given by mouth or by injection, or may be applied topically. Severe infections of the brain are usually treated with intravenous antibiotics. Sometimes, multiple antibiotics are used in case there is resistance to one antibiotic.

This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Diseases market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Antibacterial Drugs
Antiviral Drugs
Antifungal Drugs
Antiparasitic Drugs

Segmentation by application
Hospitals/Clinical Laboratories
Reference Laboratories
Academic/Research Institutes
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
F. Hoffmann-La Roche
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
Merck
Pfizer
AbbVie
Astellas Pharma
AstraZeneca
Bayer
Bristol-Myers Squibb
Chimerix Pharmaceuticals
Cubist
Eli Lilly
Isis Pharmaceuticals
Mitsubishi Tanabe Pharma
Novartis
Sanofi
Vertex

Please note: The report will take approximately 2 business days to prepare and deliver.